RT Journal Article
T1 Glomerular Diseases in Diabetic Patients: Implications for Diagnosis and Management.
A1 Oliva-Damaso, Nestor
A1 Mora-Gutiérrez, José María
A1 Bomback, Andrew S
K1 IgA nephropathy
K1 diabetes mellitus
K1 focal segmental glomerulosclerosis
K1 glomerulonephritis
K1 nondiabetic kidney disease
K1 nondiabetic renal disease
K1 obesity-related glomerulopathy
AB The prevalence of diabetes continues to rise worldwide. In addition to rising rates of diabetic kidney disease, we are also seeing a parallel rise in nondiabetic kidney disease among patients with diabetes. These nondiabetic lesions include focal segmental glomerulosclerosis, IgA nephropathy, membranous nephropathy, and other glomerular diseases. The management of diabetic kidney disease is rapidly evolving to include, beyond glycemic control and renin angiotensin inhibition, the use of sodium-glucose cotransporter 2 (SGLT2) inhibitors and mineralocorticoid receptor antagonists. These and other new treatment strategies should be applicable to managing glomerular disease in diabetic patients to reduce toxicities associated with immunosuppression and, in particular, corticosteroids. The prevalence of glomerular disease in diabetic patients is underappreciated. Diagnosis and appropriately treating these diseases remain an important avenue to modify kidney outcomes in diabetic patients.
SN 2077-0383
YR 2021
FD 2021-04-24
LK http://hdl.handle.net/10668/17706
UL http://hdl.handle.net/10668/17706
LA en
DS RISalud
RD Apr 10, 2025